Rompianesi, Gianluca
 Distribuzione geografica
Continente #
NA - Nord America 1.644
EU - Europa 421
AS - Asia 230
AF - Africa 1
SA - Sud America 1
Totale 2.297
Nazione #
US - Stati Uniti d'America 1.642
GB - Regno Unito 164
CN - Cina 90
SE - Svezia 85
SG - Singapore 70
DE - Germania 44
UA - Ucraina 39
IT - Italia 33
TR - Turchia 29
FI - Finlandia 22
HK - Hong Kong 22
BG - Bulgaria 13
IN - India 10
FR - Francia 5
RU - Federazione Russa 4
CA - Canada 2
CZ - Repubblica Ceca 2
IE - Irlanda 2
MY - Malesia 2
NL - Olanda 2
PK - Pakistan 2
BE - Belgio 1
BO - Bolivia 1
DK - Danimarca 1
ES - Italia 1
HU - Ungheria 1
ID - Indonesia 1
IR - Iran 1
KR - Corea 1
KZ - Kazakistan 1
LT - Lituania 1
RO - Romania 1
TW - Taiwan 1
UG - Uganda 1
Totale 2.297
Città #
Fairfield 224
Woodbridge 178
Chandler 151
Ashburn 148
Houston 129
Southend 128
Seattle 95
Wilmington 95
Cambridge 81
Jacksonville 76
Santa Clara 65
Singapore 62
Dearborn 52
Ann Arbor 51
Nyköping 48
San Diego 26
Hong Kong 22
New York 21
Beijing 18
Izmir 18
Fremont 15
Princeton 15
Shanghai 14
Sofia 13
Eugene 12
Helsinki 9
Modena 9
Falls Church 8
London 8
Norwalk 5
San Jose 5
Boardman 4
Des Moines 4
Frankfurt am Main 4
Munich 4
Redwood City 4
Rome 4
San Mateo 4
Bremen 3
Guangzhou 3
Hefei 3
Washington 3
Brno 2
Chicago 2
Dongguan 2
Dublin 2
Hanover 2
Hounslow 2
Kilburn 2
Leawood 2
Milan 2
Nanjing 2
Zhengzhou 2
Acton 1
Andover 1
Ardabil 1
Atlanta 1
Augusta 1
Changsha 1
Chaoyang 1
Chiswick 1
Clearwater 1
Edinburgh 1
Jakarta 1
Jinan 1
Kunming 1
La Paz 1
Lahore 1
Lappeenranta 1
Madrid 1
Miami 1
Monmouth Junction 1
Muzzana del Turgnano 1
Nanchang 1
New Orleans 1
Olgiate Olona 1
Oral 1
Pakistan 1
Panvel 1
Paris 1
Phoenix 1
Rockville 1
Saint Petersburg 1
San Francisco 1
Shaoyang 1
Stockholm 1
Taipei 1
Toronto 1
Vancouver 1
Weifang 1
Wenzhou 1
Wuhan 1
Totale 1.902
Nome #
Immunological advantages of everolimus versus cyclosporin A in liver-transplanted recipients, as revealed by polychromatic flow cytometry. 204
Absence of viable HCC in the native liver is an independent protective factor of tumor recurrence after liver transplantation 198
Temporary porto-caval shunt utility during orthotopic liver transplantation. 196
Early Withdrawal of Calcineurin Inhibitors and Everolimus Monotherapy in de novo Liver Transplant Recipients Preserves Renal Function 196
University of Modena Experience in HIV-Positive Patients Undergoing Liver Transplantation. 196
Novel genetic mutation in apolipoprotein E2 homozygosis and its implication in organ donation: a case report 191
Liver transplantation utilizing grafts from donors with genitourinary cancer detected prior to liver implantation. 191
Liver transplantation in older adults: our point of view. 189
Aseptic Osteonecrosis: A Newly Diagnosed Complication in HIV-Infected Patients Undergoing Liver Transplantation. 182
Effects of Everolimus monotherapy on hemathological parameters and iron homeostasis in de novo liver transplant resipients: preliminary results. 173
Early use of mammalian target of rapamycin inhibitors is an independent risk factor for incisional hernia development after liver transplantation. 172
High dose rabbit antithymocyte globulin induction in living related liver transplantation. 136
Neurological complications after liver transplantation as a consequence of immunosuppression: Univariate and multivariate analysis of risk factors 97
Totale 2.321
Categoria #
all - tutte 9.440
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.440


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020368 0 0 0 0 49 80 80 51 54 15 24 15
2020/2021376 33 22 24 32 50 42 16 47 18 43 24 25
2021/2022326 22 40 39 23 8 13 19 12 29 27 60 34
2022/2023335 41 48 16 41 28 49 3 34 48 2 11 14
2023/2024205 3 11 15 26 29 45 16 14 5 0 16 25
2024/2025142 13 5 8 41 75 0 0 0 0 0 0 0
Totale 2.321